---
---

# 21 U.S.C., USLM ref /us/usc/t21/s360a

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptA/m__us_usc_t21_s360.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptA/m__us_usc_t21_s360a–1.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360a)

## § 360a. Clinical trial guidance for antibiotic drugs

    (a) __In general__ 

        Not later than 1 year after September 27, 2007, the Secretary shall issue guidance for the conduct of clinical trials with respect to antibiotic drugs, including antimicrobials to treat acute bacterial sinusitis, acute bacterial otitis media, and acute bacterial exacerbation of chronic bronchitis. Such guidance shall indicate the appropriate models and valid surrogate markers.

    (b) __Review__ 

        Not later than 5 years after September 27, 2007, the Secretary shall review and update the guidance described under subsection (a) to reflect developments in scientific and medical information and technology.

([June 25, 1938, ch. 675, § 511][/us/act/1938-06-25/ch675/s511], as added [Pub. L. 110–85, title IX, § 911][/us/pl/110/85/s911], Sept. 27, 2007, [121 Stat. 951][/us/stat/121/951].)

 __Prior Provisions__ 

    A prior section 360a, [act June 25, 1938, ch. 675, § 511][/us/act/1938-06-25/ch675/s511], as added July 15, 1965, [Pub. L. 89–74, § 3(b)][/us/pl/89/74/s3/b], [79 Stat. 227][/us/stat/79/227]; amended Oct. 24, 1968, [Pub. L. 90–639, § 2(a)][/us/pl/90/639/s2/a], [82 Stat. 1361][/us/stat/82/1361], regulated the manufacture, compounding, and processing of depressant and stimulant drugs and their sale, delivery, disposal, possession, and recordkeeping activities connected therewith, prior to repeal by [Pub. L. 91–513, title II][/us/pl/91/513], §§ 701(a), 704, Oct. 27, 1970, [84 Stat. 1281][/us/stat/84/1281], 1284, effective on the first day of the seventh calendar month that began after Oct. 26, 1970.

----------

[Previous](./../../../../../..//us/usc/t21/ch9/schV/ptA/m__us_usc_t21_s360.md) | [Next](./../../../../../..//us/usc/t21/ch9/schV/ptA/m__us_usc_t21_s360a–1.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360a)

----------
----------

[/us/act/1938-06-25/ch675/s511]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1938-06-25%2Fch675%2Fs511
[/us/pl/110/85/s911]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F110%2F85%2Fs911
[/us/stat/121/951]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F121%2F951
[/us/act/1938-06-25/ch675/s511]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1938-06-25%2Fch675%2Fs511
[/us/pl/89/74/s3/b]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F89%2F74%2Fs3%2Fb
[/us/stat/79/227]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F79%2F227
[/us/pl/90/639/s2/a]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F90%2F639%2Fs2%2Fa
[/us/stat/82/1361]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F82%2F1361
[/us/pl/91/513]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F91%2F513
[/us/stat/84/1281]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F84%2F1281


